Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 12,045 | 0 | 346 | 0 | 0 |
| Gross Profit | 12,045 | N/A | 346 | N/A | N/A |
| Operating Expenses | 21,318 | 27,894 | 28,693 | 16,223 | 22,296 |
| Operating Income | -9,273 | -27,894 | -28,347 | -16,223 | -22,296 |
| Interest Expense | 7,304 | 994 | 318 | 545 | 386 |
| Other Income | 12,989 | -247 | -2 | -7 | 8 |
| Pre-tax Income | -3,588 | -29,135 | -28,667 | -16,775 | -22,674 |
| Net Income Continuous | -3,588 | -29,135 | -28,667 | -16,775 | -22,674 |
| Net Income | $-3,588 | $-29,135 | $-28,667 | $-16,775 | $-22,674 |
| EPS Basic Total Ops | -2.20 | -27.80 | -33.20 | -37.40 | -149.40 |
| EPS Basic Continuous Ops | -2.19 | -27.85 | -33.23 | -37.34 | -149.45 |
| EPS Diluted Total Ops | -2.20 | -27.80 | -33.20 | -37.40 | -149.40 |
| EPS Diluted Continuous Ops | -2.19 | -27.85 | -33.23 | -37.34 | -149.45 |
| EPS Diluted Before Non-Recurring Items | -2.20 | -27.80 | -33.20 | -37.40 | -149.40 |
| EBITDA(a) | $-1,914 | $-27,389 | $-28,386 | $-16,194 | $-22,251 |